Introduction
============

Cryptorchidism (undescended testis at birth) is the most common male congenital anomaly registered at birth or later.[@b1-clep-10-311] The condition has been associated with an increased risk of low semen quality, infertility and testicular cancer in adulthood despite routinely corrective surgery during childhood.[@b2-clep-10-311] Low birth weight and prematurity are well-documented predictors of cryptorchidism,[@b3-clep-10-311] but in most cases, the cause is unidentified. Studies have indicated that the intrauterine environment and maternal factors probably have greater influence on the risk of cryptorchidism than paternal factors or genetics.[@b4-clep-10-311] The multistage descent of the testes starts in early pregnancy around gestational week 8 and continues until approximately week 35 of gestation;[@b5-clep-10-311] thus, maternal lifestyle and environmental exposures may interfere with normal testicular descent throughout pregnancy.[@b2-clep-10-311]

Several maternal lifestyle factors have been investigated in relation to cryptorchidism such as tobacco smoking, alcohol drinking, obesity and intake of caffeinated beverages during pregnancy.[@b6-clep-10-311]--[@b35-clep-10-311] However, most studies have been small, and results are inconsistent.

Using two large population-based cohorts, we aimed to model the association between risk of cryptorchidism and the aforementioned lifestyle factors. We hypothesized that exposure to maternal tobacco smoking, prepregnancy overweight and obesity as well as maternal intake of alcohol and caffeine would lead to a higher prevalence of cryptorchidism.

Patients and methods
====================

Study population
----------------

The study utilized data from the Danish National Birth Cohort (DNBC) and the Aarhus Birth Cohort (ABC). The DNBC is a nationwide birth cohort that enrolled pregnant women from 1996 to 2002. All pregnant Danish-speaking women in Denmark who wanted to carry their pregnancy to term were eligible. Approximately 60% of the invited women participated and took part in four computer-assisted telephone interviews, two of them conducted during pregnancy: the earliest around gestational week 12, and then again at approximately gestational week 30.[@b36-clep-10-311],[@b37-clep-10-311]

The ABC is an ongoing pregnancy cohort established in 1989. All pregnant women attending routine antennal care at Aarhus University Hospital, Denmark, have since 1989 been invited to participate by completing a self-administered questionnaire around the time of late first or early second trimester on lifestyle during pregnancy as well as on the medical and obstetric history. Until now, \~80% of the invited women have participated.[@b38-clep-10-311],[@b39-clep-10-311]

For this study, we included women enrolled in the two birth cohorts, who gave birth to a live-born singleton boy from 1989 to 2012. Women were eligible if they had completed one of the prenatal interviews (DNBC) or questionnaires (ABC) and had a valid unique civil registration number. Since 1968, the Danish Civil Registration System has been assigning a unique civil registration number to all residents,[@b40-clep-10-311] which is used in the health care system in Denmark. This unique identifier was used to link the data from the birth cohorts with the following national health registries: the Danish Medical Birth Register, with information regarding the pregnancy;[@b41-clep-10-311] the Danish National Patient Register, with information on all diagnosis- and surgical codes for all in- and outpatient hospital contacts,[@b42-clep-10-311] and the Danish Integrated Database for Labour Market Research, with information on social data.[@b43-clep-10-311]

Exposure assessment
-------------------

The exposures used in this study were the following maternal lifestyle factors; tobacco smoking, average alcohol intake and binge drinking, prepregnancy body mass index (BMI) as well as intake of caffeine from coffee, tea and cola beverages.

In the DNBC, this information was available from the telephone interviews. We used the first interview around gestational week 12 as the main source of exposure information. This was chosen to obtain a shorter recall period. If this information was missing, we used the information from the telephone interview around week 30.

In the ABC, information on maternal lifestyle came from the self-administered questionnaires. In the early period of the ABC (1989--1999), some women completed a second questionnaire in early third trimester, and if information was missing from the first questionnaire in early pregnancy, we used the information from the second. For those women who were included in both DNBC and ABC (n=3,479), we used the information from the DNBC. If data on either maternal tobacco smoking or maternal height or weight were missing from both birth cohorts, we used information from the Danish Medical Birth Register on maternal tobacco smoking (n = 230, available from 1996 to 2012) and maternal weight and height (n = 58 and n = 106, available from 2004 to 2012).

### Maternal tobacco smoking

Maternal tobacco smoking during pregnancy was categorized as follows: non-smoking, stopped smoking in first trimester and 1--9, 10--14 or ≥15 cigarettes/day. Because of a higher nicotine content in other tobacco products than in cigarettes, we multiplied the numbers of cigars, cheroots and pipes by 4. "Stopped smoking" were women who reported to have smoked at the first detection of pregnancy or in very early pregnancy and did not smoke when they were interviewed (DNBC) or completed the questionnaires (ABC).

### Maternal weekly alcohol intake

Maternal weekly alcohol intake during pregnancy was based on the combined average weekly intake of alcoholic beverages. One alcoholic drink was defined as one glass of wine, one bottle of beer (0.33 L) or one glass of liqueur (12.5 g alcohol/unit). The total weekly intake was categorized into 0--\<1, 1--2, 3--4 and ≥5 drinks.

### Maternal binge drinking

Maternal binge drinking was categorized according to the frequency of drinking five or more alcoholic drinks in one occasion, i.e., binge drinking episodes since the onset of pregnancy. We categorized the number of binge drinking episodes during pregnancy as 0, 1, 2 and ≥3 times. In ABC, questions on maternal binge drinking were not included in the early part of the cohort (1989--1998), so we limited our analysis on binge drinking in ABC to 1998 and onward.

### Maternal prepregnancy BMI

Maternal prepregnancy BMI (kg/m^2^) was calculated and categorized according to the World Health Organization classification: underweight: \<18.5 kg/m^2^, normal weight: 18.5--24.9 kg/m^2^, overweight: 25--29.9 kg/m^2^ and obese: ≥30 kg/m^2^.[@b44-clep-10-311] Outliers with excessively high or low values were recoded to missing.

### Maternal caffeine intake

Maternal caffeine intake during pregnancy was based on caffeine intake from coffee, tea and cola and was categorized into 0, 1--300, 301--600 and ≥600 mg caffeine/day. We defined one cup of coffee as 100 mg of caffeine, one cup of tea as 50 mg of caffeine and 1/2 L of cola as 50 mg of caffeine according to published literature.[@b45-clep-10-311],[@b46-clep-10-311]

Covariates
----------

Information on covariates were either self-reported or retrieved from the Danish health registers[@b41-clep-10-311] A priori, potential mediators and confounders for the five different exposures were identified by the existing literature and the use of directed acyclic graphs (DAGs).[@b47-clep-10-311] In all models, we adjusted for years of education (≤9, 10--14 and ≥15 years), maternal age at birth (\<25, 25--29, 30--34 and ≥35 years), parity (nulliparous and multiparous women), birth cohort (ABC or DNBC) and calendar year at birth (1989--1993, 1994--1998, 1999--2003, 2004--2008 and 2009--2012), the latter to account for the trend in the prevalence of diagnosed male genital anomalies in the Danish National Patient Register, the difference in follow-up time and the change in registration from International Classification of Diseases (ICD) version 8 to version 10 during the study period. The analyses for maternal tobacco smoking, maternal caffeine intake and maternal weekly alcohol intake and binge drinking were further adjusted for time to pregnancy (unplanned pregnancies, 0--5 months, 6--12 months and ≥12 months without assisted reproductive technology (ART) and ≥12 months with ART). The five exposures were mutually adjusted.

Outcome measures
----------------

We studied two outcomes. The first was boys with a cryptorchidism diagnosis, defined as a diagnosis of cryptorchidism according to ICD-8 (1977--1993): 75210, 75211, 75219 and ICD-10 (1994--2012): Q53. Second, we used a definition with higher positive predictive value[@b48-clep-10-311] and classified boys as having cryptorchidism if they had both a diagnosis of cryptorchidism and underwent corrective surgery for cryptorchidism (orchiopexy). The Nordic classification of surgical procedures codes: KKFH00, KKFH01, KKFH10 or surgery and treatment classification of the Danish National Board of Health codes: 55640, 55600 was used to define orchiopexy.

Missing information
-------------------

Missing data ranged from none for, e.g., maternal age, calendar year of birth and birth cohort, to 11.6% for maternal binge drinking ([Table 1](#t1-clep-10-311){ref-type="table"}). Ignoring maternal binge drinking, 84% of the study population had complete information on all exposures, covariates and the outcomes.

We accounted for missing data by using multiple imputation.[@b49-clep-10-311] This is a method widely recommended if data are missing at random (MAR);[@b49-clep-10-311] data is considered to be almost MAR if the systematic difference between observed and missing values can be "explained" by the observed data, an assumption we assumed.[@b50-clep-10-311] Current guidelines recommend that the number of imputations should be at least equal to the percentage of incomplete cases.[@b51-clep-10-311] We fitted a multiple imputation model using chained equations and imputed 50 datasets with the following variables included in the model: maternal tobacco smoking (continuous), maternal weekly alcohol intake (categorical), maternal binge drinking (continuous), maternal prepregnancy weight and height (continuous), maternal caffeine intake (continuous), cryptorchidism, hypospadias, other malformations, maternal years of education (categorical), maternal age at birth (continuous), time to pregnancy (categorical), ART (binary), parity (categorical), nausea (binary), calendar year at birth (continuous), birth weight (continuous), gestational age (continuous) and type of cohort. Continuous variables were interval censored to ensure biologically plausible values. Binary variables were modeled using the logit function and continuous variables using the linear regression. Maternal prepregnancy weight was right skewed and transformed to approximate normality by a shifted logarithm transformation.[@b51-clep-10-311]

Data analyses
-------------

Cryptorchidism is by definition present at birth but may not be diagnosed at birth; the condition may thus be diagnosed at any time during childhood.[@b3-clep-10-311],[@b52-clep-10-311] By the end of follow-up (December 31, 2012), not all boys in the DNBC and the ABC were of the same age. To account for this variation in followup time, we used a Cox proportional hazards model, with the boy's age as the underlying time axis. The boys entered the risk set at birth and were followed until their age at diagnosis of cryptorchidism, death, emigration from Denmark, or the end of follow-up, whichever came first. Crude and adjusted hazard ratios (HRs) with 95% CI for cryptorchidism according to the different maternal lifestyle factors were estimated. Since the cohorts included siblings, the CIs were calculated using robust standard errors with the mother as cluster identifier. The proportional hazards assumption was verified by visual inspection of log-minus-log plots. Overall statistical significance for each exposure variable was tested using the Wald test or a test for linear trend.

We performed the following subanalyses. First, a sub-analysis on the association between paternal smoking and cryptorchidism was conducted to investigate potential familial confounding. Second, we carried out a subanalysis, restricting our study population to DNBC that holds information on nausea, because women with coffee aversion and nausea are probably more likely to lower their coffee intake. Further, it has been proposed that nausea is an indicator of viability of the fetus, reflecting a healthy hormone balance in the pregnancy.[@b76-clep-10-311] Third, we fitted a multiple imputation model with 100 datasets and compared the results to the main analysis using 50 datasets to check the validity of our imputation model. We compared the main result with results from a complete case analysis, and finally, we performed sepa rate analyses in the two cohorts. Data were analyzed using STATA version 11.2 at Statistics Denmark with encrypted identification numbers and no contact with individuals. The study was approved by the Danish Data Protection Agency (No. 2013-41-1964).

Results
=======

From the DNBC, 46,165 live-born singleton boys born from 1996 to 2003 and from the ABC 39,758 live-born singleton boys born from 1989 to 2012 were included in this study. This added up to a final study population of 85,923 mother--son pairs. Of them, 1,864 (2.2%) boys were diagnosed with cryptorchidism (1,076 from the DNBC and 788 from the ABC), and 1,098 (59%) of them underwent corrective surgery (627 from the DNBC and 471 from the ABC). The mean (range) follow-up time was 12 years (range 0--23 years).

[Table 1](#t1-clep-10-311){ref-type="table"} lists distribution of the five exposures and relevant covariates according to cryptorchidism with and without corrective surgery. The following appeared to be more frequent among mothers of boys with cryptorchidism: tobacco smoking, overweight and obesity, caffeine intake during pregnancy, maternal age \<25 years at birth and short education, nulliparity, time to pregnancy of \>12 months with and without ART and giving birth between 1989 and 1993.

[Table 2](#t2-clep-10-311){ref-type="table"} presents the adjusted HRs of cryptorchidism according to the maternal lifestyle factors of interest. We observed associations between maternal tobacco smoking and maternal prepregnancy BMI and occurrence of cryptorchidism.

We observed higher HR for cryptorchidism with higher exposure to maternal tobacco smoking during pregnancy, and compared to the unexposed, boys of mothers who smoked 10--14 cigarettes/day had the highest HRs for cryptorchidism (HR: 1.37; 95% CI: 1.06--1.76). Sons of mothers who stopped smoking in early pregnancy also had a slightly higher HR of cryptorchidism (HR: 1.16; 95% CI: 0.96--1.41). For maternal BMI, we observed a dose--response-like association. Sons of obese mothers (BMI: ≥30 kg/m^2^) had the highest HR for cryptorchidism (HR: 1.32; 95% CI: 1.06--1.65). Maternal weekly alcohol intake during pregnancy was not associated with cryptorchidism. However, one or two binge-drinking episodes during pregnancy were associated with a slightly lower HR for cryptorchidism in sons compared with no binge drinking. Finally, maternal caffeine intake during pregnancy was not associated with cryptorchidism. Results from analyses of all diagnosed boys with cryptorchidism were similar to those verified by surgery.

The subanalysis on the association between paternal smoking and cryptorchidism, showed no association (data not shown). Adjusting for nausea did not change the results on the association between caffeine intake during pregnancy and cryptorchidism (data not shown). Furthermore, we checked the robustness of the multiple imputation model and found similar results when imputing 100 datasets instead of 50 datasets (data not shown). The results of the complete case analyses were similar to our main results as presented ([Table S1](#SD1-clep-10-311){ref-type="supplementary-material"}). Finally, stratifying by type of birth cohorts gave only small differences in the results. However, the association between prepregnancy obesity and risk of cryptorchidism was stronger in ABC compared with DNBC, and binge drinking was only associated with decreased risk in DNBC ([Table S2](#SD2-clep-10-311){ref-type="supplementary-material"}).

Discussion
==========

In this large population-based study; maternal tobacco smoking during pregnancy and prepregnancy overweight and obesity were associated with a higher occurrence of cryptorchidism in sons. Our results indicated no associations between weekly alcohol consumption or caffeine intake during pregnancy and cryptorchidism at the levels consumed in these cohorts. Counterintuitively, one to two binge drinking episodes were associated with HRs \<1 for cryptorchidism, which could be a chance finding.

Among women who stopped smoking in early pregnancy, we observed risks of cryptorchidism similar to women smoking one to nine cigarettes during pregnancy, which may reflect the importance of the early prenatal exposure to tobacco smoking, where the fetus is more vulnerable. On the other hand, it could also indicate that these women actually were heavy smokers before pregnancy and share characteristics with smokers. In a subanalysis, we found no association between paternal smoking and cryptorchidism, but the association was strengthened when both parents smoked compared to maternal smoking alone. This could indicate that the sons were exposed to more passive smoking. It could also suggest that these women smoke to a larger extent and exposed the fetus for a longer period or more extensively than those women with a nonsmoking partner. Smoking is thought to induce hypoxia in the fetus caused by the vasoconstrictive effects of nicotine[@b55-clep-10-311] but contains thousands of other potentially toxic chemicals[@b56-clep-10-311] and is also associated with deficient or altered androgen signaling.[@b57-clep-10-311] Although the majority of existing literature does not support an association between smoking and cryptorchidism,[@b8-clep-10-311],[@b9-clep-10-311],[@b12-clep-10-311]--[@b14-clep-10-311],[@b17-clep-10-311],[@b19-clep-10-311],[@b23-clep-10-311]--[@b25-clep-10-311],[@b27-clep-10-311]--[@b31-clep-10-311],[@b34-clep-10-311],[@b35-clep-10-311] our results are consistent with five previous studies,[@b7-clep-10-311],[@b11-clep-10-311],[@b22-clep-10-311],[@b26-clep-10-311] including those of a large Danish pregnancy cohort study by Jensen et al[@b22-clep-10-311] that also found a higher risk among sons exposed to \>10 cigarettes/day.

Alcohol consumption during pregnancy is suspected to modify sex hormone levels in utero, which are essential for the descent of the testes.[@b58-clep-10-311] However, our results point toward a lower occurrence of cryptorchidism among sons of mothers who reported binge drinking during pregnancy. A majority of previous studies reported no association between weekly alcohol intake and cryptorchidism.[@b9-clep-10-311],[@b11-clep-10-311],[@b12-clep-10-311],[@b17-clep-10-311],[@b19-clep-10-311],[@b21-clep-10-311],[@b25-clep-10-311],[@b26-clep-10-311],[@b28-clep-10-311],[@b29-clep-10-311],[@b32-clep-10-311],[@b35-clep-10-311] A few studies have suggested a higher risk among binge drinkers[@b21-clep-10-311],[@b32-clep-10-311] and yet others have observed a dose--response-like relationship with weekly alcohol consumption during pregnancy.[@b13-clep-10-311],[@b15-clep-10-311] A meta-analysis by Zhang et al[@b33-clep-10-311] indicated a lower risk of cryptorchidism in sons of pregnant women with low-to-moderate alcohol intake, whereas more than five drinks per week was associated with a higher risk. Our findings for binge drinking could be due to chance, selection bias, information bias or uncontrolled confounding, which is likely, as women binge drinking before versus after recognition of pregnancy have previously been shown to differ on other maternal characteristics in DNBC.[@b59-clep-10-311] Separating the two cohorts showed that the HR between binge drinking and cryptorchidism was only \<1 in DNBC, indicating that the women in this cohort may be healthier.[@b60-clep-10-311]

Maternal overweight and obesity during pregnancy are associated with aberrant glycemic control and a less healthy nutritional status of the pregnant women.[@b61-clep-10-311] It has previously been associated with other congenital anomalies.[@b62-clep-10-311] In case of cryptorchidism, results have been mixed with some showing an association, whereas others not.[@b6-clep-10-311],[@b9-clep-10-311],[@b10-clep-10-311],[@b12-clep-10-311],[@b14-clep-10-311],[@b16-clep-10-311],[@b18-clep-10-311],[@b23-clep-10-311]--[@b26-clep-10-311],[@b31-clep-10-311],[@b33-clep-10-311],[@b34-clep-10-311],[@b63-clep-10-311] A recent register-based Swedish study by Arendt et al,[@b63-clep-10-311] including 1,055,705 boys, found results similar to ours regarding cryptorchidism and obesity.

High caffeine consumption during pregnancy has previously been associated with pregnancy complications[@b64-clep-10-311] and fetal death.[@b65-clep-10-311] Maternal caffeine intake could result in disturbed development of the fetus because of uteroplacental vasoconstriction due to rise in maternal serum catecholamine levels and reduced blood flow to the placenta.[@b66-clep-10-311] However, we found no indication to support an effect of caffeine on the risk of cryptorchidism. Only three case--control studies with a small sample size have explored the relation between maternal caffeine levels and cryptorchidism with different results.[@b9-clep-10-311],[@b20-clep-10-311],[@b28-clep-10-311]

The discrepancies in previous studies on maternal lifestyle and cryptorchidism in boys could be caused by differences in ascertainment of cryptorchidism. We have classified boys with cryptorchidism using both registration of diagnosis and corrective surgery from the Danish National Patient Registry, which has been shown to have a high positive predictive value.[@b48-clep-10-311]

The present study provides sufficient power to investigate our hypotheses, although some exposures only had few highly exposed. In addition to the high number of participants, another major strength of this study was the detailed prospectively collected information on lifestyle factors and potential confounding factors from the two Danish birth cohorts. Thus, we were able to adjust for several potential confounders, yet residual confounding or confounding from unknown factors cannot be ruled out. For instance, we did not have information about diet and nutrition, and nutritional deficiencies may well be a potential confounder. We were to some extent limited by lack of information on coffee aversion and nausea in ABC, and therefore, we restricted a subanalysis to DNBC that holds information on nausea. These analyses gave results comparable to our main results.

In both the DNBC and the ABC, the participation rate was \~60% and 80%, and we used the Danish health care registers with negligible loss to follow-up. Selection bias due to nonparticipation at inclusion in both cohorts cannot be rejected but is probably not a major problem because of the early inclusion prior to the end point registration of genital anomalies or other pregnancy outcomes. Yet, participation may be associated with both the exposure and potential factors directly linked to cryptorchidism, such as time to pregnancy or prior congenital malformations. We assume that this will only be of minor importance.[@b60-clep-10-311] Furthermore, our imputed model yielded results similar to the complete case analysis. We only included live-born singleton boys, which could be a potential selection problem often referred to as live--birth bias.[@b67-clep-10-311] The lifestyle factors are all associated with a higher risk of fetal death,[@b65-clep-10-311],[@b68-clep-10-311]--[@b70-clep-10-311] and among fetal deaths, the occurrence of congenital abnormalities is high.[@b71-clep-10-311] If the most highly exposed fetuses died before birth, it could theoretically have biased our results toward the null. However, cryptorchidism is a milder congenital malformation unrecognized before birth; we therefore consider this to be a minor issue.

We expect some degree of misclassification and recall bias; however, we consider it likely to be mostly non-differential, as information on lifestyle factors was collected in early pregnancy by telephone interviews in DNBC and self-administered questionnaires in ABC.

A large Norwegian cohort study comparing self-reported smoking status and plasma cotinine concentrations revealed that self-reported smoking is a valid marker for tobacco exposure in utero.[@b72-clep-10-311] Further, to evaluate the validity of our tobacco smoking information, we corroborated the well-known reduction in birth weight with increasing levels of tobacco smoking during pregnancy.[@b53-clep-10-311] Boys exposed to 15 or more cigarettes per day on average had 292 grams (95 % CI: −318; −266) lower birth weight than sons of non-smokers. Information on maternal alcohol intake may to some extent be underreported[@b73-clep-10-311],[@b74-clep-10-311] due to the widespread consensus that alcohol consumption during pregnancy may damage the fetus. However, interviews and questionnaires have been shown to be reliable methods to collect information on the overall distribution of alcohol consumption in pregnant Danish women.[@b73-clep-10-311] In addition, body weight tends to be underreported, and there might also be some degree of misclassification in our data.[@b75-clep-10-311] We consider information about caffeine consumption not to be underreported, mainly because intake of coffee, tea and cola during pregnancy is widely accepted in Denmark. In addition, we were able to include caffeine exposure not only from tea and coffee consumption but also from intake of cola. Caffeine content depends highly on types of coffee, tea and cola and brewing methods. Unfortunately, this type of data was unavailable.

This study benefits from the use of two large birth cohorts, and by virtue of the study strengths and limitations, we believe that these findings are rather valid and may apply to other populations. Future studies could, if possible, look at siblings with different in utero exposure to limit the unmeasured time stable confounding.

Conclusion
==========

In this large population-based cohort study, maternal tobacco smoking during pregnancy and maternal prepregnancy obesity were associated with an increased occurrence of cryptorchidism in sons, while alcohol or caffeine intake was not.

Supplementary materials
=======================

###### 

HRs for cryptorchidism according to maternal smoking, weekly alcohol intake, binge drinking, prepregnancy BMI and caffeine intake during pregnancy among 85,923 singleton live-born boys, Denmark, 1989--2012 (Complete case)

  Characteristic                                                                  Distribution of participants, %   Cryptorchidism -- diagnosis   Cryptorchidism -- surgery                                              
  ------------------------------------------------------------------------------- --------------------------------- ----------------------------- --------------------------- ------ --------------- ----- ------ ------ --------------
  **Smoking (cigarettes/day)[a](#tfn8-clep-10-311){ref-type="table-fn"}**                                                                                                                                                
  Complete observations[a](#tfn8-clep-10-311){ref-type="table-fn"}                84.2                                                                                                                                   
  Nonsmoker                                                                       73.8                              2.0                           1.00                        1.00   Reference       1.2   1.00   1.00   Reference
  Stopped smokers                                                                 9.7                               2.5                           1.22                        1.20   (1.02--1.41)    1.4   1.19   1.19   (0.97--1.47)
  1--9                                                                            8.6                               2.4                           1.10                        1.13   (0.95--1.34)    1.5   1.17   1.21   (0.97--1.52)
  10--14                                                                          4.7                               2.7                           1.21                        1.26   (1.01--1.57)    1.8   1.40   1.58   (1.21--2.06)
  ≥15                                                                             2.9                               2.6                           1.18                        1.00   (0.73--1.36)    1.5   1.13   0.90   (0.59--1.39)
  Wald test                                                                                                                                                                          *p=*0.06                            *p=*0.01
  **Alcohol (drinks/week)[b](#tfn9-clep-10-311){ref-type="table-fn"}**                                                                                                                                                   
  Complete observations[b](#tfn9-clep-10-311){ref-type="table-fn"}                84.2                                                                                                                                   
  None to \<1                                                                     70.8                              2.2                           1.00                        1.00   Reference       1.3   1.00   1.00   Reference
  1--2                                                                            19.7                              2.2                           0.88                        0.92   (0.81--1.04)    1.2   0.84   0.88   (0.74--1.04)
  3--4                                                                            3.9                               2.1                           0.93                        0.81   (0.61--1.07)    1.3   0.97   0.93   (0.66--1.30)
  ≥5                                                                              1.6                               1.4                           0.71                        0.73   (0.45--1.17)    1.1   0.90   0.83   (0.47--1.47)
  Wald test                                                                                                                                                                          *p=*0.17                            *p=*0.47
  **Binge drinking episodes(times)**[b](#tfn9-clep-10-311){ref-type="table-fn"}                                                                                                                                          
  Complete observations[b](#tfn9-clep-10-311){ref-type="table-fn"}                82.7                                                                                                                                   
  None                                                                            61.6                              2.3                           1.00                        1.00   Reference       1.4   1.00   1.00   Reference
  1                                                                               16.6                              1.8                           0.85                        0.83   (0.71--0.98)    1.1   0.86   0.79   (0.64--0.96)
  2                                                                               6.3                               1.8                           0.85                        0.79   (0.62--1.01)    1.0   0.80   0.67   (0.49--0.93)
  ≥3                                                                              3.9                               2.2                           1.03                        0.92   (0.69--1.22)    1.4   1.14   0.94   (0.66--1.33)
  Wald test                                                                                                                                                                          *p*=0.05                            *p*=0.02
  **Prepregnancy BMI (kg/m^2^)**[c](#tfn10-clep-10-311){ref-type="table-fn"}                                                                                                                                             
  Complete observations[c](#tfn10-clep-10-311){ref-type="table-fn"}               86.5                                                                                                                                   
  \<18.5                                                                          4.9                               2.3                           1.12                        1.08   (0.86--1.36)    1.3   1.03   0.98   (0.73--1.33)
  18.5--24.9                                                                      67.3                              2.0                           1.00                        1.00   Reference       1.2   1.00   1.00   Reference
  25--29.9                                                                        16.8                              2.6                           1.33                        1.33   (1.17--1.51)    1.4   1.19   1.18   (1.00--1.40)
  ≥30                                                                             6.8                               2.6                           1.30                        1.26   (1.05 --1.52)   1.6   1.34   1.30   (1.02--1.64)
  Wald test                                                                                                                                                                          *p=*0.00                            *p=*0.06
  **Caffeine (mg/day)[d](#tfn11-clep-10-311){ref-type="table-fn"}**                                                                                                                                                      
  Complete observations[d](#tfn11-clep-10-311){ref-type="table-fn"}               84.2                                                                                                                                   
  None                                                                            9.4                               1.9                           0.98                        0.96   (0.80--1.16)    1.0   0.98   0.95   (0.75--1.21)
  1--300                                                                          64.4                              2.1                           1.00                        1.00   Reference       1.3   1.00   1.00   Reference
  400--600                                                                        14.3                              2.4                           1.05                        1.08   (0.93--1.24)    1.4   1.01   1.03   (0.85--1.24)
  \>600                                                                           5.5                               2.5                           1.06                        1.11   (0.90--1.37)    1.5   1.04   1.11   (0.85--1.45)
  Wald test                                                                                                                                                                          *p=*0.59                            *p=*0.85

**Notes:**

Adjusted for maternal years of education, maternal age at delivery, parity, calendar year, cohort, mothers' caffeine intake and alcohol intake, maternal prepregnancy BMI and time to index pregnancy.

Adjusted for maternal years of education, maternal age at delivery, parity, calendar year, cohort, mothers' caffeine intake and smoking, maternal prepregnancy BMI and time to index pregnancy.

Adjusted for maternal years of education, maternal age at delivery, parity, calendar year, cohort, mothers' caffeine intake and alcohol intake and maternal smoking during pregnancy.

Adjusted for maternal years of education, maternal age at delivery, parity, calendar year, cohort, mothers' alcohol intake and smoking, maternal prepregnancy BMI and time to index pregnancy.

**Abbreviations:** HR, hazard ratio; BMI, body mass index; aHR, adjusted hazard ratio.

###### 

HRs for cryptorchidism according to maternal smoking, weekly alcohol intake, binge drinking, prepregnancy BMI and caffeine intake in ABC and the DNBC among 85,923 singleton live-born boys, Denmark, 1989--2012 (Complete case stratified by birth cohort)

  Characteristic                                                                    DNBC (n = 46,165)   ABC (n = 39,758)                                                           
  --------------------------------------------------------------------------------- ------------------- ------------------ ------ ------ -------------- ------ ----- ------ ------ --------------
  **Smoking (cigarettes/day)[a](#tfn13-clep-10-311){ref-type="table-fn"}**                                                                                                         
  Nonsmoker                                                                         74.4                1.3                1.00   1.00   Reference      73.1   1.1   1.00   1.00   Reference
  Stopped smokers                                                                   9.1                 1.6                1.29   1.26   (0.97--1.63)   10.4   1.3   1.07   1.09   (0.77--1.54)
  1--9                                                                              9.0                 1.5                1.15   1.16   (0.88--1.54)   8.2    1.6   1.20   1.29   (0.89--1.86)
  10--14                                                                            4.6                 2.1                1.64   1.66   (1.19--2.32)   4.9    1.6   1.14   1.43   (0.91--2.25)
  ≥15                                                                               2.9                 1.5                1.18   0.99   (0.59--1.65)   3.0    1.4   1.07   0.75   (0.34--1.66)
                                                                                    0.1                                                                 0.5                        
  **Alcohol (drinks/week)[b](#tfn14-clep-10-311){ref-type="table-fn"}**                                                                                                            
  None to \<1                                                                       70.9                1.4                1.00   1.00   Reference      70.6   1.2   1.00   1.00   Reference
  1--2                                                                              24.4                1.2                0.86   0.88   (0.72--1.07)   14.1   1.1   0.79   0.90   (0.65--1.24)
  3--4                                                                              3.6                 1.3                0.94   0.88   (0.55--1.40)   4.4    1.3   1.01   1.01   (0.61--1.66)
  ≥5                                                                                1.0                 1.3                0.88   0.96   (0.43--2.15)   2.3    1.0   0.91   0.73   (0.32--1.66)
                                                                                    0.1                                                                 8.6                        
  **Binge drinking episodes (times)[b](#tfn14-clep-10-311){ref-type="table-fn"}**                                                                                                  
  None                                                                              74.8                1.4                1.00   1.00   Reference      35.1   1.2   1.00   1.00   Reference
  1                                                                                 16.0                1.1                0.78   0.74   (0.58--0.94)   17.9   1.0   1.06   0.98   (0.66--1.44)
  2                                                                                 5.6                 1.0                0.67   0.57   (0.37--0.88)   7.8    1.1   1.07   0.93   (0.55--1.55)
  ≥3                                                                                3.5                 1.5                1.04   0.93   (0.61--1.42)   4.8    1.4   1.34   1.02   (0.54--1.92)
                                                                                    0.2                                                                 34.4                       
  **Prepregnancy BMI (kg/m^2^)[c](#tfn15-clep-10-311){ref-type="table-fn"}**                                                                                                       
  \<18.5                                                                            4.3                 1.5                1.12   1.08   (0.74--1.57)   5.5    1.1   0.94   0.85   (0.51--1.41)
  18.5--24.9                                                                        64.2                1.3                1.00   1.00   Reference      70.9   1.1   1.00   1.00   Reference
  25--29.9                                                                          18.4                1.5                1.11   1.10   (0.90--1.36)   14.9   1.4   1.32   1.36   (1.03--1.81)
  ≥30                                                                               7.7                 1.6                1.21   1.21   (0.91--1.61)   5.7    1.6   1.59   1.54   (1.01--2.34)
                                                                                    5.3                                                                 2.9                        
  **Caffeine (mg/day)[d](#tfn16-clep-10-311){ref-type="table-fn"}**                                                                                                                
  0                                                                                 6.6                 1.4                1.01   1.03   (0.74--1.42)   12.6   1.0   0.92   0.87   (0.61--1.24)
  1--300                                                                            70.0                1.3                1.00   1.00   Reference      57.9   1.2   1.00   1.00   Reference
  301--600                                                                          16.1                1.5                1.08   1.07   (0.85--1.35)   12.3   1.3   0.91   0.96   (0.69--1.33)
  \>600                                                                             7.1                 1.4                1.06   1.08   (0.78--1.48)   3.5    1.5   1.01   1.23   (0.75--2.03)
                                                                                    0.1                                                                 13.6                       

**Notes:**

Adjusted for maternal years of education, maternal age at delivery, parity, calendar year, cohort, mothers' caffeine intake and alcohol intake, maternal prepregnancy BMI and time to index pregnancy.

Adjusted for maternal years of education, maternal age at delivery, parity, calendar year, cohort, mothers' caffeine intake and smoking, maternal prepregnancy BMI and time to index pregnancy.

Adjusted for maternal years of education, maternal age at delivery, parity, calendar year, cohort, mothers' caffeine intake and alcohol intake and maternal smoking during pregnancy.

Adjusted for maternal years of education, maternal age at delivery, parity, calendar year, cohort, mothers' alcohol intake and smoking, maternal prepregnancy BMI and time to index pregnancy.

**Abbreviations:** HR, hazard ratio; BMI, body mass index; ABC, Aarhus Birth Cohort; DNBC, Danish National Birth Cohort; aHR, adjusted hazard ratio.
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###### 

Distribution of maternal characteristics according to cryptorchidism among 85,923 singleton live-born boys, Denmark, 1989--2012

  Characteristic                        Distribution of participants, %   Cryptorchidism   Cryptorchidism -- corrective surgery                                          
  ------------------------------------- --------------------------------- ---------------- -------------------------------------- -------- ------ ------- ----- -------- ------
  **Total**                                                               1,864            2.2                                    84,059   97.8   1,098   1.3   84,825   98.7
  **Smoking (cigarettes/day)**                                                                                                                                           
  Nonsmoker                             73.8                              1,289            2.0                                    62,117   98.0   752     1.2   62,654   98.8
  Stopped smokers                       9.7                               211              2.5                                    8,118    97.5   120     1.4   8,209    98.6
  1--9                                  8.6                               180              2.4                                    7,229    97.6   112     1.5   7,297    98.5
  10--14                                4.7                               110              2.7                                    3,946    97.3   74      1.8   3,982    98.2
  ≥15                                   2.9                               66               2.6                                    2,450    97.4   37      1.5   2,479    98.5
  Missing                               0.2                                                                                                                              
  **Alcohol (drinks/week)**                                                                                                                                              
  None to \<1                           70.8                              1,341            2.2                                    59,456   97.8   792     1.3   60,005   98.7
  1--2                                  19.7                              351              2.2                                    16,539   97.9   197     1.2   16,693   98.7
  3--4                                  3.9                               71               2.1                                    3,314    97.9   44      1.3   3,341    98.7
  ≥5                                    1.6                               20               1.4                                    1,378    98.6   15      1.1   1,383    98.9
  Missing                               4.0                                                                                                                              
  **Binge drinking episodes (times)**                                                                                                                                    
  0                                     61.6                              991              2.3                                    41,658   97.7   592     1.4   42,057   98.6
  1                                     16.6                              208              1.8                                    11,298   98.2   125     1.1   11,381   98.9
  2                                     6.3                               78               1.8                                    4,299    98.2   44      1.0   4,333    99.0
  ≥3                                    3.9                               59               2.2                                    2,646    97.8   39      1.4   2,666    98.6
  Missing                               11.6                                                                                                                             
  **Prepregnancy BMI (kg/m^2^)**                                                                                                                                         
  \<18.5                                4.9                               95               2.3                                    4,097    97.7   53      1.3   4,139    98.7
  18.5--24.9                            67.3                              1,145            2.0                                    56,672   98.0   696     1.2   57,121   98.8
  25--29.9                              16.8                              378              2.6                                    14,073   97.4   205     1.4   14,246   98.6
  ≥30                                   6.8                               149              2.6                                    5,699    97.5   93      1.6   5,755    98.4
  Missing                               4.2                                                                                                                              
  **Caffeine (mg/day)**                                                                                                                                                  
  0                                     9.4                               149              1.9                                    7,925    98.2   89      1.1   7,985    98.9
  1--300                                64.4                              1,161            2.1                                    54,198   97.9   697     1.3   54,662   98.7
  301--600                              14.3                              293              2.4                                    12,032   97.6   169     1.4   12,156   98.6
  \>600                                 5.5                               116              2.5                                    4,587    97.5   68      1.5   4,635    98.6
  Missing                               6.4                                                                                                                              
  **Age at delivery (years)**                                                                                                                                            
  \<25                                  10.8                              247              2.7                                    9,031    97.3   145     1.6   9,133    98.4
  25--29                                37.5                              672              2.1                                    31,524   97.9   405     1.3   31,791   98.7
  30--34                                36.3                              659              2.1                                    30,544   97.9   387     1.2   30,816   98.8
  \>35                                  15.4                              286              2.2                                    12,960   97.8   161     1.2   13,085   98.8
  Missing                               0                                                                                                                                
  **Parity (before this birth)**                                                                                                                                         
  0                                     48.3                              979              2.4                                    40,492   97.6   583     1.4   40,888   98.6
  ≥1                                    51.6                              885              2.0                                    43,498   98.0   515     1.2   43,868   98.8
  Missing                               0.1                                                                                                                              
  **Education (years)**                                                                                                                                                  
  Short ≤9                              10.1                              225              2.6                                    8,438    97.4   122     1.4   8,541    98.6
  Medium 10--14                         42.1                              806              2.2                                    35,323   97.8   485     1.3   35,644   98.7
  Long ≥15                              47.2                              826              2.0                                    39,698   98.0   488     1.2   40,036   98.8
  Missing                               0.7                                                                                                                              
  **Time to pregnancy (months)**                                                                                                                                         
  0--5                                  50.4                              889              2.1                                    42,424   98.0   525     1.2   42,788   98.8
  6--12                                 12.7                              240              2.2                                    10,695   97.8   142     1.3   10,793   98.7
  ≥12 without ART                       5.7                               121              2.5                                    4,796    97.5   72      1.5   4,845    98.5
  ≥12 with ART                          5.3                               108              2.4                                    4,453    97.6   68      1.5   4,493    98.5
  Unplanned                             19.2                              370              2.2                                    16,124   97.8   226     1.4   16,268   98.6
  Missing                               6.6                                                                                                                              
  DNBC                                  53.7                              1,076            2.3                                    45,089   97.7   627     1.4   45,538   98.6
  ABC                                   46.3                              788              2.0                                    38,970   98.0   471     1.2   39,287   98.8
  Missing                               0                                                                                                                                
  **Calendar year of birth**                                                                                                                                             
  1989--1993                            7.7                               218              2.8                                    7,523    97.2   129     1.7   7,612    98.3
  1994--1998                            17.3                              368              2.5                                    14,525   97.5   192     1.3   14,701   98.7
  1999--2003                            55.4                              1,080            2.3                                    46,482   97.7   640     1.4   46,922   98.7
  2004--2008                            10.8                              155              1.7                                    9,125    98.3   106     1.1   9,174    98.9
  2009--2012                            7.5                               43               0.7                                    6,404    99.3   31      0.5   6,416    99.5
  Missing                               0                                                                                                                                

**Abbreviations:** BMI, body mass index; ART, assisted reproductive technology; DNBC, Danish National Birth Cohort; ABC, Aarhus Birth Cohort.

###### 

HRs for cryptorchidism according to maternal smoking, weekly alcohol intake, binge drinking, prepregnancy BMI and caffeine intake during pregnancy among 85,923 singleton live-born boys, Denmark 1989--2012[a](#tfn2-clep-10-311){ref-type="table-fn"}

  Characteristic                                                                   Distribution of participants, %   Cryptorchidism   Cryptorchidism -- surgery                                             
  -------------------------------------------------------------------------------- --------------------------------- ---------------- --------------------------- ------ -------------- ----- ------ ------ --------------
  **Smoking (cigarettes/day)[b](#tfn3-clep-10-311){ref-type="table-fn"}**                                                                                                                                   
  Nonsmoker                                                                        73.8                              2.0              1.00                        1.00   Reference      1.2   1.00   1.00   Reference
  Stopped smokers                                                                  9.7                               2.5              1.22                        1.19   (1.03--1.38)   1.4   1.19   1.16   (0.96--1.41)
  1--9                                                                             8.9                               2.5              1.12                        1.07   (0.91--1.25)   1.5   1.17   1.15   (0.93--1.41)
  10--14                                                                           4.7                               2.7              1.21                        1.13   (0.92--1.39)   1.8   1.40   1.37   (1.06--1.76)
  ≥15                                                                              2.9                               2.6              1.18                        1.09   (0.84--1.42)   1.5   1.13   1.11   (0.78--1.57)
  Test for trend                                                                                                                                                  1.01   (1.00--1.02)                1.02   (1.00--1.03)
  Wald test[b](#tfn3-clep-10-311){ref-type="table-fn"}                                                                                                                   *p*=0.17                    *p*    =0.10
  **Alcohol (drinks/week)[c](#tfn4-clep-10-311){ref-type="table-fn"}**                                                                                                                                      
  None to \<1                                                                      74.1                              2.2              1.00                        1.00   Reference      1.3   1.00   1.00   Reference
  1--2                                                                             20.1                              2.1              0.87                        0.89   (0.79--1.00)   1.2   0.83   0.85   (0.73--1.00)
  3--4                                                                             4.1                               2.1              0.92                        0.91   (0.71--1.16)   1.3   0.96   0.96   (0.70--1.30)
  ≥5                                                                               1.7                               1.4              0.71                        0.69   (0.44--1.08)   1.1   0.90   0.87   (0.52--1.45)
  Test for trend                                                                                                                                                  0.91   (0.84--0.99)                0.93   (0.83--1.03)
  Wald test[c](#tfn4-clep-10-311){ref-type="table-fn"}                                                                                                                   *p*=0.10                    *p*    =0.27
  **Binge drinking episodes (times)[c](#tfn4-clep-10-311){ref-type="table-fn"}**                                                                                                                            
  None                                                                             66.3                              2.2              1.00                        1.00   Reference      1.3   1.00   1.00   Reference
  1                                                                                21.2                              1.7              0.85                        0.83   (0.71--0.96)   1.0   0.87   0.81   (0.67--0.98)
  2                                                                                8.2                               1.6              0.85                        0.80   (0.64--1.01)   1.0   0.82   0.74   (0.54--1.00)
  ≥3                                                                               4.3                               2.1              1.01                        0.92   (0.71--1.20)   1.4   1.11   0.96   (0.69--1.34)
  Test for trend                                                                                                                                                  0.94   (0.89--1.00)                0.94   (0.87--1.02)
  Wald test[c](#tfn4-clep-10-311){ref-type="table-fn"}                                                                                                                   *p=*0.03                    *p*    =0.05
  **BMI (kg/m^2^)[d](#tfn5-clep-10-311){ref-type="table-fn"}**                                                                                                                                              
  \<18.5                                                                           5.3                               2.3              1.11                        1.08   (0.88--1.33)   1.3   1.03   1.00   (0.76--1.32)
  18.5--24.9                                                                       69.9                              2.0              1.00                        1.00   Reference      1.2   1.00   1.00   Reference
  25--29.9                                                                         17.9                              2.6              1.31                        1.33   (1.18--1.49)   1.4   1.17   1.18   (1.01--1.38)
  ≥30                                                                              7.0                               2.6              1.29                        1.29   (1.09--1.54)   1.6   1.33   1.32   (1.06--1.65)
  Wald test[d](#tfn5-clep-10-311){ref-type="table-fn"}                                                                                                            1.02   (1.01--1.03)         1.01          (1.00--1.03)
  Test for trend                                                                                                                                                         *p*=0.00                           *p*=0.03
  **Caffeine (mg/day)**[e](#tfn6-clep-10-311){ref-type="table-fn"}                                                                                                                                          
  None                                                                             9.4                               1.9              0.98                        0.97   (0.81--1.15)   1.1   0.99   0.94   (0.75--1.18)
  1--300                                                                           67.6                              2.1              1.00                        1.00   Reference      1.3   1.00   1.00   Reference
  301--600                                                                         16.9                              2.4              1.07                        1.06   (0.93--1.21)   1.4   1.02   1.02   (0.85--1.21)
  \>600                                                                            6.1                               2.6              1.09                        1.06   (0.87--1.30)   1.5   1.06   1.02   (0.79--1.33)
  Wald test[e](#tfn6-clep-10-311){ref-type="table-fn"}                                                                                                            1.00   (1.00--1.00)         1.00          (1.00--1.00)
  Test for trend                                                                                                                                                         *p*=0.77                           *p=*0.96

**Notes:**

50 imputed sets.

Adjusted for maternal years of education, maternal age at delivery, parity, calendar year, cohort, mothers' caffeine intake and alcohol intake, maternal prepregnancy BMI and time to index pregnancy.

Adjusted for maternal years of education, maternal age at delivery, parity, calendar year, cohort, mothers' caffeine intake and smoking, maternal prepregnancy BMI and time to index pregnancy.

Adjusted for maternal years of education, maternal age at delivery, parity, calendar year, cohort, mothers' caffeine intake and alcohol intake and maternal smoking during pregnancy.

Adjusted for maternal years of education, maternal age at delivery, parity, calendar year, cohort, mothers' alcohol intake and smoking, maternal prepregnancy BMI and time to index pregnancy.

**Abbreviations:** HR, hazard ratio; BMI, body mass index; aHR, adjusted hazard ratio.
